Editorial


There is a time for changing, always. It responds to the need to grow up, to reinvent ourselves. D.A. has gotten to its turning point, aiming to focus on core topics for the scientific panel and at the same time, spreading the knowledge about model experiences, highly representing the Italian excelence in research and innovation. Key word, innovation: to this element, a new specific section will...



 
 

Bio Banks: a fundamental support for research

Interviewing CEO of BioRep
It is vital for healthcare and biotechnologies to count on innovative structures able to preserve big quantities of biological material, necessary to research on genetic, tumoral, neurodegenerative diseases, for the longest time and in the best conditions possible....



 
 

Sapio Award for the Italian Research: Study Day Health and Biotechnologies


Along the XIVth edition of the Award, in Florence an important scientific event was organized about rare and neurodegenerative diseases. The hall “Sala D’Arme” in Palazzo Vecchio, in Piazza della Signoria in Firenze was the marvellous frame of the Study Day dedicated to Health and Biotechnologies, organized along the annual edition of Sapio Award. The municipality of Florence hosted this...



 
 

Michael J. Fox Foundation, a model for accelerating translational research

By , Associate director of research programs Michael J. Fox Foundation for Parkinson’s Research
Parkinson’s disease (PD) is a progressive neurodegenerative disease that affects nearly one million Americans and five million people worldwide. There is no effective therapy to modify the progression of the disease, and current therapies to treat motor and non-motor symptoms are inadequate, leaving...



 
 

Overview of CHDI's Huntington disease's drug development programs

Di , CSO - CHDI Foundation

CHDI Foundation, Inc., is a US nonprofit drug discovery organisation that is exclusively dedicated to accelerating the discovering and development of therapeutics that slow the progression of Huntington’s...



 
 

Personalized Medicine in Multiple Sclerosis

By Special Professor of Neurology and Director of the Specialization School Università Vita - Salute, San Raffaele HospitalThe rapid development of powerful molecular biology tools in biomedical research...


 
 

Innovation Dossier | ADIENNE - Pharma & Biotech

Interview to , Adienne CEO

 
 

Innovation Dossier | The activity of the NRI Center (Italian acronym CERM)

By and , CERM, University of Firenze

The Center for Magnetic Resonance is a Research, transferring and High...



 
 

Innovation Dossier | I.C.F.: a standard instrument to classify functioning, disability and health

By , Eubios S.r.l.

 
We are introducing...



 
 

Rare diseases: the patient is the starting point

By , Director of Farmacologia Molecolare, IRBM PROMIDIS

Rare diseases have mostly...



 
 

AIFA commitment in the name of exchange and clearness

By General Manager AIFA
 
The first mission for AIFA is make the access to medicines required by patients easier and is the principle I have spread from...



 
 

New hopes for type 1 diabetes from stem cells

By Tor Vergata University (Rome) e  Harvard Medical School, Boston e San Raffaele Hospital (Milan)

Stamina cells represent an important...



 
 

Research and economical sustainability in ageing Italy

By  Responsible for the research in CNR - National Council for Research - and Institute for the study of Neuropathologies, Padova



 
 
Archivio numeri precedenti